Last Updated: April 16, 2026 · Medically Reviewed by Dr. Elena Foster, MD
GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Zepbound) have dominated weight-loss conversations since 2023. They genuinely work for many users — often producing 15–20% body weight loss. But the full picture is more complicated than the marketing suggests.
GLP-1 receptor agonists mimic glucagon-like peptide-1, a hormone that slows gastric emptying, suppresses appetite, and supports insulin response. When taken weekly as an injection, they dramatically reduce food intake — many users report simply losing interest in food. The weight loss that follows is substantial: clinical trials show mean losses of 15–20% of body weight over 68 weeks for semaglutide at the higher doses.
For someone with significant obesity (BMI 30+) who has struggled with weight for years, these results can be life-changing. GLP-1s aren't snake oil — they work through a legitimate hormonal mechanism with extensive clinical evidence.
What gets downplayed in the marketing: the side effect profile is substantial. Common effects include nausea (experienced by 40%+ of users), vomiting, diarrhea, constipation, stomach pain, and reduced appetite to the point of under-eating. More serious risks include gallbladder problems, pancreatitis, thyroid tumors (black box warning), and gastroparesis (delayed stomach emptying that can persist after stopping the drug).
The cosmetic effects are also worth mentioning: "Ozempic face" (visible facial fat loss that can age appearance), muscle loss alongside fat loss (requiring resistance training to mitigate), and loose skin in people losing 50+ pounds.
Without insurance coverage, Ozempic runs $900–$1,300 per month in the US. Wegovy is similar. Insurance coverage has been inconsistent — many plans cover it only for diabetes, not weight loss. Many users pay out of pocket or use compounded versions with unclear quality controls.
Perhaps the most significant issue: weight returns when you stop. Research has documented that people who discontinue GLP-1s typically regain two-thirds of the weight lost within a year. This means these drugs aren't really a weight-loss treatment — they're a maintenance therapy, and the cost/side effect burden continues indefinitely.
For people with mild to moderate weight goals (less than 50 lbs to lose), natural approaches — diet modification, exercise, and targeted supplements — are often sufficient and appropriate. The effect size is smaller (5–15% body weight loss over 6–12 months is realistic) but so is the side effect burden, the cost, and the dependency.
Combination supplements like Leanzene that combine ACV and BHB ketones target appetite and energy metabolism — two of the same systems GLP-1s address, but more gently. No GI side effects at the level of Ozempic. No prescription required. A fraction of the cost. Not appropriate for severe obesity where medical intervention is justified, but a reasonable first-line approach for the larger population of people with moderate weight-management goals.
GLP-1 drugs may be appropriate for: BMI 30+ with comorbidities, BMI 35+ without comorbidities, type 2 diabetes (where GLP-1s are approved for glycemic control), people who've struggled with significant weight for years despite sustained effort. Always under physician supervision.
Natural approaches (diet + activity + supplements) may be more appropriate for: Mild to moderate weight goals (5–30 lbs), people who haven't yet tried consistent lifestyle approaches, people sensitive to GLP-1 side effects, people for whom cost is prohibitive, and anyone who prefers to exhaust non-pharmaceutical options first.
Honest answer: no, not for the same magnitude of weight loss. Ozempic typically produces 15–20% body weight loss; natural approaches (diet + activity + supplements) typically produce 5–15%. However, for people whose weight-loss goals fall in the 5–15% range, natural approaches are often sufficient, with far fewer side effects and lower cost.
Consult your physician before combining. The theoretical concern is that both could compound GI effects (nausea, slow gastric emptying). Some people transitioning off GLP-1s use supplements to support the transition. This is a decision to make with your prescriber, not independently.
Yes, like any significant weight loss, Ozempic-induced loss tends to include roughly 30–40% lean mass alongside fat mass unless actively countered. Adequate protein intake (0.8–1.0g per pound of goal weight) and resistance training 2–3 times per week are essential to preserve muscle during any weight loss approach, GLP-1 or otherwise.
Research shows roughly two-thirds of the weight lost typically returns within a year of discontinuation. The appetite-suppressing effects disappear within weeks, and the same food patterns that drove weight gain initially re-emerge. This is why GLP-1s function more as ongoing maintenance than as a time-limited weight-loss treatment.
Leanzene combines Apple Cider Vinegar with three BHB ketone salts in one daily gummy. 60-day money-back guarantee. Explore the Leanzene ACV + BHB formula as a natural alternative.
Get Leanzene — From $49/Bottle